Galera Therapeutics Inc. (GRTX)
$0.09
$0.05
(123.10%)
As on 12-Jun-2026 12:59EDT
Market cap
$19 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0.1
P/B Ratio
27.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-10.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
203,268,886
7 Years Aggregate
CFO
$-308.00 Mln
EBITDA
$-338.31 Mln
Net Profit
$-382.40 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Galera Therapeutics (GRTX)
| -- | -- | -- | -- | -70.3 | -60.7 | -- |
|
BSE Sensex
| -10.8 | -0.6 | -1.7 | -8.5 | 6.4 | 7.6 | 11.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|
|
Galera Therapeutics (GRTX)
| -90.3 | -67.5 | -55.1 | -22.3 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Galera Therapeutics (GRTX)
|
0.1 | 19.3 | 0.0 | 149.0 | -- | -- | 0.1 | 27.9 |
| 283.0 | 40,461.0 | 4,286.9 | 577.2 | 9.8 | 88.2 | 76.3 | 37.6 | |
| 53.1 | 13,246.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 17.5 | 6.8 | |
| 131.2 | 16,655.9 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 179.4 | 30,617.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 22.8 | 5.0 | |
| 480.3 | 11,227.7 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 20.9 | |
| 468.8 | 12,973.2 | 2,678.3 | 460.4 | 21.1 | 103.2 | 28.6 | 21.9 | |
| 614.6 | 66,620.0 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 15.5 | 2.1 | |
| 540.6 | 23,340.2 | 3,169.8 | 1,287.4 | 51.4 | 20.6 | 20.3 | 4.0 | |
| 444.1 | 113,407.9 | 12,255.1 | 4,338.3 | 31.7 | 23.7 | 26.5 | 5.9 |
Shareholding Pattern
View DetailsAbout Galera Therapeutics (GRTX)
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a... pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC). The company was incorporated in 2012 and is based in Malvern, Pennsylvania. Read more
-
CEO, President & Director
Dr. J. Mel Sorensen M.D.
-
CEO, President & Director
Dr. J. Mel Sorensen M.D.
-
Headquarters
Malvern, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Galera Therapeutics (GRTX)
What is the current share price of Galera Therapeutics Inc (GRTX) Today?
The share price of Galera Therapeutics Inc (GRTX) is $0.09 (NASDAQ) as of 12-Jun-2026 12:59 EDT. Galera Therapeutics Inc (GRTX) has given a return of -70.26% in the last 3 years.
What is the current PB & PE ratio of Galera Therapeutics Inc (GRTX)?
The P/E ratio of Galera Therapeutics Inc (GRTX) is 0.15 times as on 05-Jun-2026.
The P/B ratio of Galera Therapeutics Inc (GRTX) is 27.92 times as on 05-Jun-2026, a 586 premium to its peers’ median range of 4.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
-0.13
|
-0.06
|
|
2022
|
-0.67
|
-0.38
|
|
2021
|
-1.38
|
-2.09
|
What is the 52 Week High and Low of Galera Therapeutics Inc (GRTX)?
The 52-week high and low of Galera Therapeutics Inc (GRTX) are Rs 0.09 and Rs 0.09 as of 13-Jun-2026.
What is the market cap of Galera Therapeutics Inc (GRTX)?
Galera Therapeutics Inc (GRTX) has a market capitalisation of $ 19 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Galera Therapeutics Inc (GRTX)?
Before investing in Galera Therapeutics Inc (GRTX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.